Position in MNKD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,094,891
+$356,448 QoQ
Shares Held
2,895,874
+143.7% QoQ
Ownership
0.937%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 99.76183356043806.ToString("F0")%
Shared 0.ToString("F0")%
None 0.23816643956194225.ToString("F0")%
Common Shares in MNKD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,509,413,147 across 314 Biotechnology names. MNKD ranks #86 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in MNKD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,094,891 | 2,895,874 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,738,443 | 1,188,438 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,794,972 | 2,010,237 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,447,225 | 2,525,996 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,893,858 | 3,358,620 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $20,409,874 | 3,174,164 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,116,744 | 3,039,228 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,744,422 | 2,824,602 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,876,353 | 2,400,961 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,691,425 | 1,014,128 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,508,437 | 2,302,285 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,042,038 | 2,221,631 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $12,592,965 | 3,071,455 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,835,899 | 1,486,888 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $331,791 | 107,376 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,561,740 | 934,840 | Shares | Sole | 2022-08-15 | |
| 2021-06-30 | $310,497 | 56,972 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,616,305 | 1,942,935 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $4,147,300 | 1,325,016 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,807,326 | 1,493,259 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,232,233 | 1,275,562 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||